Time to Recurrence, but Not Recurrence-Free Survival, Should Be the Endpoint Used to Predict Early Recurrence after HCC Resection
Wen-Tao Yan,Bing Quan,Hao Xing,Meng-Chao Wu,Tian Yang
DOI: https://doi.org/10.1016/j.jhep.2018.10.025
IF: 25.7
2019-01-01
Journal of Hepatology
Abstract:Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resectionJournal of HepatologyVol. 69Issue 6PreviewWorldwide, hepatocellular carcinoma (HCC) is the sixth most frequent malignancy and the second most common cause of cancer-related death.1 There is a wide variety of therapeutic options for patients with HCC, depending on tumour burden, liver function and performance status.2 Potentially curative therapy recommended for those patients with very early/early stage tumour (Barcelona Clinic Liver Cancer [BCLC] 0/A) consists of surgical resection, liver transplantation or local ablation. Because of the scarcity of donor organs, surgical resection and ablation are the mainstay of curative treatment options in Asian-Pacific countries, which account for three-quarters of all new patients globally. Full-Text PDF Open AccessReply to: Correspondence concerning “Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection”Journal of HepatologyVol. 70Issue 3PreviewWe are grateful for the interest in, and comment on,1–4 our recent paper concerning early recurrence after resection of hepatocellular carcinoma (HCC).5 Full-Text PDF We read with great interest the article by Dr. Chan et al.[1]Chan A.W.H. Zhong J. Berhane S. Toyoda H. Cucchetti A. Shi K. et al.Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection.J Hepatol. 2018; 69: 1284-1293Abstract Full Text Full Text PDF PubMed Scopus (216) Google Scholar In this study, gender, preoperative albumin-bilirubin (ALBI) grade, preoperative alpha-fetoprotein (AFP) level, tumor size, tumor number, and microvascular invasion were revealed as independent predictors associated with early recurrence after resection of hepatocellular carcinoma (HCC). Using these independent predictors, the authors developed and validated 2 models for predicting early recurrence, i.e., the preoperative model (ERASL-pre) and the postoperative model (ERASL-post). Based on these 2 models, the authors conducted risk stratification to better determine the risk of early recurrence for patients undergoing HCC resection. However, for both model establishment and risk stratification, the authors adopted recurrence-free survival (RFS) as the study endpoint. In terms of the optimal study endpoint and the enrolled clinical variables in this study, we have the following comments: In the ‘Patients and methods’ section, the authors defined RFS as “the time from date of curative surgery to the time of recurrence”, and “patients with no recurrent disease were censored at the last time at which they were known to be recurrence free”. However, the description mentioned above is not the generally-recognized definition of RFS, but always regarded as the definition of time to recurrence (TTR). Actually, in most previous studies, RFS is generally defined as “the time from date of curative surgery to the time of recurrence or death”. In other words, if a patient died without recurrence in the follow-up after surgery, it should be considered as an endpoint for RFS but not a censored event. For example, 1 male patient died of decompensated cirrhosis at the 10th month after resection of HCC, but recurrence did not occur at the time of death. For this patient, the RFS should be considered as having an endpoint event (defined as “1”), while the TTR should be considered as a censored event (defined as “0”). Although the time of RFS and TTR is the same (10 months), it was totally different between the 2 final events. We believe that TTR, rather than RFS, may be the optimal study endpoint for predicting early recurrence after HCC resection. Additionally, what puzzled us was that in this study, ALBI grade, an indicator of hepatic function, was an independent predictor of early recurrence after HCC resection. It is commonly known that early recurrence is most likely the consequence of occult metastasis from the initial tumor, and those aggressive tumor characteristics, including large tumor size, multi-nodularity, poor tumor differentiation, microvascular and macrovascular invasion, and satellite nodules, have been demonstrated to be associated with early recurrence after HCC resection in numerous previous studies.2Wu J.C. Huang Y.H. Chau G.Y. Su C.W. Lai C.R. Lee P.C. et al.Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma.J Hepatol. 2009; 51: 890-897Abstract Full Text Full Text PDF PubMed Scopus (318) Google Scholar, 3Imamura H. Matsuyama Y. Tanaka E. Ohkubo T. Hasegawa K. Miyagawa S. et al.Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.J Hepatol. 2003; 38: 200-207Abstract Full Text Full Text PDF PubMed Scopus (1154) Google Scholar, 4Shirabe K. Kanematsu T. Matsumata T. Adachi E. Akazawa K. Sugimachi K. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses.Hepatology. 1991; 14: 802-805Crossref PubMed Scopus (310) Google Scholar, 5Portolani N. Coniglio A. Ghidoni S. Giovanelli M. Benetti A. Tiberio G.A. et al.Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications.Ann Surg. 2006; 243: 229-235Crossref PubMed Scopus (638) Google Scholar, 6Poon R.T. Fan S.T. Ng I.O. Lo C.M. Liu C.L. Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma.Cancer. 2000; 89: 500-507Crossref PubMed Scopus (648) Google Scholar, 7Shah S.A. Greig P.D. Gallinger S. Cattral M.S. Dixon E. Kim R.D. et al.Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes.J Am Coll Surg. 2006; 202: 275-283Abstract Full Text Full Text PDF PubMed Scopus (212) Google Scholar Furthermore, in these studies, those characteristics reflecting preoperative hepatic function, such as the Child-Pugh grade, the ALBI grade, and the model for end-stage liver disease score, were always proven to be associated with worse survival rate after HCC resection, instead of early recurrence. Therefore, we wonder if Chan et al. used RFS (considering recurrence and death as an end event), but not TTR (only considering recurrence as an end event) as the study endpoint for multivariate Cox-regression analyses in their study. Last but not least, the authors adopted many clinical variables to set up preoperative and postoperative models for predicting early recurrence before and after surgery, respectively. In most cases, some clinical variables for developing the preoperative model are usually based on preoperative imaging findings, while some clinical variables for developing the postoperative model are often derived from postoperative pathological examinations of specimens.8Yang P. Qiu J. Li J. Wu D. Wan X. Lau W.Y. et al.Nomograms for pre- and postoperative prediction of long-term survival for patients who underwent hepatectomy for multiple hepatocellular carcinomas.Ann Surg. 2016; 263: 778-786Crossref PubMed Scopus (51) Google Scholar, 9Li Y. Xia Y. Li J. Wu D. Wan X. Wang K. et al.Prognostic nomograms for pre- and postoperative predictions of long-term survival for patients who underwent liver resection for huge hepatocellular carcinoma.J Am Coll Surg. 2015; 221: 962-974.e4Abstract Full Text Full Text PDF PubMed Scopus (24) Google Scholar, 10Shim J.H. Jun M.J. Han S. Lee Y.J. Lee S.G. Kim K.M. et al.Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma.Ann Surg. 2015; 261: 939-946Crossref PubMed Scopus (165) Google Scholar The determinations of some clinical variables, including tumor size, tumor number, and gross/macroscopic vascular invasion, would overlap but lead to different results between preoperative imaging findings and postoperative pathological examinations. However, in Chan et al.’s study, the analyses of tumor size and tumor number used the same data both before and after surgery. The authors should explain clearly which results the predictive variables, used to develop their 2 models, were based on – the preoperative imaging findings or the postoperative pathological examinations. In summary, clarification regarding these issues would greatly solidify the conclusions of Chan et al.’s study. This work was supported in part by the National Natural Science Foundation of China (No. 81472284 and 81672699), and Shanghai Pujiang Program (No. 16PJD004). All authors have declared no conflict of interest. Please refer to the accompanying ICMJE disclosure forms for further details. Conception: Wen-Tao Yan, Hao Xing, Tian Yang; Manuscript preparation: Wen-Tao Yan, Bing Quan, Hao Xing; Critical revision: Meng-Chao Wu, Tian Yang. All the authors reviewed the paper and approved the final version. Wen-Tao Yan, Bing Quan, and Hao Xing contribute equally to this work. The following are the Supplementary data to this article: Download .pdf (.26 MB) Help with pdf files Supplementary Data 1